INTRASENSE (EPA:ALINS)

BRIEF

published on 06/08/2026 at 15:18, 10 days 9 hours ago

Intrasense and Guerbet Secure PMDA Certification in Japan for DUOnco™ Pancreas

International Expansion AI Medical Imaging Pancreatic Cancer Detection PMDA Certification Japan CT Scan Enhancement
BRIEF

published on 06/08/2026 at 15:16, 10 days 9 hours ago

PMDA Certification for DUOnco™ Pancreas in Japan

Medical Imaging Pancreatic Cancer AI Diagnostics DUOnco™ Pancreas PMDA Certification
PRESS RELEASE

published on 06/08/2026 at 15:13, 10 days 9 hours ago

Intrasense and Guerbet announce PMDA certification in Japan for DUOnco™ Pancreas, an AI software designed to support the reading of pancreatic areas on contrast-enhanced CT
Intrasense and Guerbet announce PMDA certification in Japan for DUOnco™ Pancreas, an AI software designed to support the reading of pancreatic areas on contrast-enhanced CT

AI Software Guerbet Intrasense DUOnco™ Pancreas PMDA Certification
BRIEF

published on 02/05/2026 at 15:34, 4 months 13 days ago

Intrasense Revenue Rises 43% in 2025

Order Intake Intrasense Revenue Myrian® Sales AI-enhanced Imaging CE Markings
BRIEF

published on 02/05/2026 at 15:31, 4 months 13 days ago

Intrasense: Revenue growth of 43% by 2025

Intrasense Myrian® Revenue 2025 AI Medical Imaging Growth In Europe
PRESS RELEASE

published on 02/05/2026 at 15:29, 4 months 13 days ago

Annual revenue for 2025 up 43% to €3.2 million, in line with annual targets
Intrasense reports 43% revenue increase to €3.2 million in 2025, meeting targets. Strong international sales for Myrian®. Innovation strategy with certifications

Revenue Increase Certifications Financial Targets Intrasense Myrian
BRIEF

published on 12/18/2025 at 18:03, 6 months ago

Intrasense: Confirmation of 2025 Objectives and Strategic Adjustment

Innovation Medical Imaging Intrasense Geographic Expansion 2025 Goals
PRESS RELEASE

published on 08/13/2025 at 16:03, 10 months 5 days ago

INTRASENSE : DUOnco™ Pancreas CE marking: a key innovation for the early detection of pancreactic cancer using AI
Intrasense obtains CE marking under MDR for DUOnco™ Pancreas, an AI solution enhancing early detection of pancreatic cancer. CEO Alexandre Salvador highlights the innovation's importance in clinical practice and patient care

AI Pancreatic Cancer CE Marking Intrasense DUOnco Pancreas
BRIEF

published on 08/13/2025 at 15:59, 10 months 5 days ago

Intrasense Obtains CE Certification for DUOnco™ Pancreas, a Breakthrough in Oncology

Artificial Intelligence Oncology CE Certification Intrasense DUOnco™ Pancreas
BRIEF

published on 07/28/2025 at 10:40, 10 months 21 days ago

Half-Yearly Review of the Intrasense Liquidity Contract

Liquidity Contract Actions Stock Market Transactions FASD Intrasense

Published on 06/19/2026 at 00:00, 41 minutes ago

Redwood AI Announces Initiation of Chemical Risk Assessment Module
Published on 06/18/2026 at 23:55, 46 minutes ago

Relevant Gold Announces Results of Annual and Special General Meeting and Welcomes New Board Member
Published on 06/18/2026 at 23:30, 1 hour 11 minutes ago

American Critical Minerals Extends Early Warrant Exercise Incentive Program
Published on 06/18/2026 at 23:00, 1 hour 41 minutes ago

Jaguar Mining Inc. Annual General Meeting of Shareholders Voting Results
Published on 06/18/2026 at 18:00, 6 hours 41 minutes ago

BEACN Closes Second Series Under Loan Program and Previews BEACN App Version 1.4

View all ACCESSWIRE

Published on 06/18/2026 at 22:35, 2 hours 6 minutes ago

Bitmine Immersion Technologies Announces Cash Dividend of $0.1056 per Share of 9.50% Series A Perpetual Preferred Stock
Published on 06/18/2026 at 22:00, 2 hours 41 minutes ago

Blue Cap AG: Closing of the Acquisition of Janoschka AG Successfully Completed
Published on 06/18/2026 at 18:55, 5 hours 46 minutes ago

Holding(s) in Company
Published on 06/18/2026 at 18:55, 5 hours 46 minutes ago

Holding(s) in Company
Published on 06/18/2026 at 18:30, 6 hours 11 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

View all EQS

Published on 06/18/2026 at 18:00, 6 hours 41 minutes ago

Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 6 hours 56 minutes ago

EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:38, 7 hours 3 minutes ago

Statement of transactions in own shares from June 8, 2026 to June 12, 2026
Published on 06/18/2026 at 13:00, 11 hours 41 minutes ago

Edenred statement
Published on 06/18/2026 at 09:06, 15 hours 35 minutes ago

Eiffage, member of the NSORe joint venture, wins the contract for a converter station for the NSC2 offshore grid connection project in Germany

View all LES ECHOS COMFI WIRE

News